# US 2025/0019758 A1 · Controlled polynucleotide translocation in nanopore sequencing

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0019758 A1
- Document ID: US20250019758A1
- Status: Published application
- Kind: A1
- Application number: 18/650,800
- Filed: 2024-04-30
- Published: 2025-01-16
- Earliest claimed: 2023-05-03
- Assignees: Illumina, Inc.
- Applicants: Illumina, Inc.
- Inventors: Abdul Sadeer Abd Salam; Xiangyuan Yang; Hassan Zakiruddin Bohra; Yin Nah Teo; Tsz Ying Yuen; Daniel Hartoyo Lukamto; Erin Garcia; Jeffrey G. Mandell
- Web page: https://patentgrep.com/patent/US20250019758A1

## CPC

- C12Q 1/6869: Methods for sequencing
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- G01N 33/48721: {Investigating individual macromolecules, e.g. by translocation through nanopores (Coulter counters in general G01N15/12; fabrication methods for nanoscale apertures B81B1/00; sequencing of nucleic acids C12Q1/68)}
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Provided herein are methods for modification-based controlled polynucleotide translocation in nanopores for sequencing, modified nucleotides, and kits and systems for performing the disclosed methods. In some embodiments, modifications can be used to control polynucleotide translocation by modifying nucleotides on a strand of polynucleotide to carry a modification, where the modifications can arrest or slow translocation when encountering the nanopore. In some embodiments, application of a voltage can move one nucleotide and its attached modification through the nanopore at a time.

## Claims

### Claim 1

A method for determining a sequence of a target polynucleotide with a nanopore-based sequencing system, the method comprising:
providing a target polynucleotide comprising nucleotides, wherein each nucleotide comprises a modification, wherein the modification comprises an arresting construct configured to arrest translocation of the target polynucleotide through a nanopore;
applying a driving voltage to translocate one or more portions of the target polynucleotide through a nanopore;
measuring a current of the nanopore continuously during translocation; and
identifying the sequence of the target polynucleotide by correlating the measured current to an identity of one or more nucleotides.

### Claim 2 (depends on 1)

The method of claim 1, wherein providing the target polynucleotide comprises synthesizing a daughter strand based on a template polynucleotide using nucleotides with modifications, wherein the modifications are covalently attached to the nucleotides.

### Claim 3 (depends on 1)

The method of any one of claim 1, wherein the modification further comprises a cyclic loop, wherein the arresting construct is attached to the cyclic loop.

### Claim 4 (depends on 3)

The method of claim 3, wherein the cyclic loop further comprises a reporter element that encodes the nucleotide.

### Claim 5 (depends on 4)

The method of claim 4, wherein the cyclic loop further comprises a spacer.

### Claim 6 (depends on 1)

The method of claim 1, wherein providing the target polynucleotide comprises:
synthesizing a daughter strand based on a template polynucleotide using nucleotides with modifications, wherein the modifications are covalently attached to the nucleotides; and
cleaving the daughter strand to generate the target polynucleotide having an elongated polynucleotide strand.

### Claim 7 (depends on 1)

The method of claim 1, wherein the nucleotide has a dwell time in the nanopore of greater than 5 ms.

### Claim 8 (depends on 1)

The method of claim 1, wherein the nucleotide has a dwell time in the nanopore of greater than 0.1 ms.

### Claim 9 (depends on 1)

The method of claim 1, wherein the driving voltage is kept constant during the translocation.

### Claim 10 (depends on 4)

The method of claim 4, wherein the measured current is dependent on the reporter element or the nucleotide passing through the nanopore.

### Claim 11 (depends on 1)

The method of claim 1, wherein the arresting construct comprises a polymer selected from the group consisting of a linear synthetic hydrophilic polymer, linear synthetic hydrophobic polymer, linear polynucleotide, linear polypeptide, branched polymer, dendritic polymer, cyclic polymer, fluoroalkyl, rigid conjugated chromophores, and rigid macrocycles.

### Claim 12 (depends on 11)

The method of claim 11, wherein the arresting construct comprises a covalent coupling between the polymer and the corresponding nucleotide or a cyclic loop.

### Claim 13 (depends on 12)

The method of claim 12, wherein the covalent coupling is selected from the group consisting of amine-NHS ester, amine-imidoester, amine-pentofluorophenyl ester, amine-hydroxymethyl phosphine, carboxyl-carbodiimide, thiol-maleimide, thiol-haloacetyl, thiol-pyridyl disulfide, thiol-thiosulfonate, thiol-vinyl sulfone, aldehyde-hydrazide, aldehyde-alkoxyamine, hydroxy-isocyanate, azide-alkyne, azide-phosphine, transcyclooctene-tetrazine, norbornene-tetrazine, azide-cyclooctyne, and azide-norbornene.

### Claim 14 (depends on 11)

The method of claim 11, wherein the linear synthetic hydrophilic polymer is selected from the group consisting of polyethyleneglycol, polyvinylalcohol, polyacrylamide, polyvinylpyrrolidone, polystyrenesulfonate, polyethyleneimine, and a combination thereof.

### Claim 15 (depends on 11)

The method of claim 11, wherein the linear synthetic hydrophobic polymer is selected from the group consisting of polylactic acid, polymethymethacrylate, polystyrene, and a combination thereof.

### Claim 16 (depends on 11)

The method of claim 11, wherein the linear polynucleotide is a homopolymer of a natural nucleotide, a homopolymer of an unnatural nucleotide, a mixed sequence polymer of natural nucleotides, or a mixed sequence polymer of unnatural nucleotides.

### Claim 17 (depends on 11)

The method of claims 11, wherein the linear polypeptide comprises one or more types of amino acids.

### Claim 18 (depends on 11)

The method of claim 11, wherein the branched polymer comprises 2 or more branches.

### Claim 19 (depends on 11)

The method of any one of claims 11, wherein the cyclic polymer has 3 or more repeating units.

### Claim 20 (depends on 19)

The method of claim 19, each repeating unit is a small molecule, a nucleotide, or an amino acid.

### Claim 21 (depends on 19)

The method of claim 19, wherein the repeating units are the same.

### Claim 22 (depends on 19)

The method of claim 19, wherein at least two of the repeating units are different.

### Claim 23 (depends on 1)

The method of claim 1, wherein the arresting construct interacts with the nanopore via a non-covalent interaction.

### Claim 24 (depends on 23)

The method of claim 23, wherein the non-covalent interaction comprises electrostatic interactions, ion-dipole interactions, dipole-dipole interactions, hydrophobic interactions, and combinations thereof.

### Claim 25 (depends on 1)

A system for determining a sequence of a target polynucleotide using a method according to claim 1.

### Claim 26

A cyclic loop nucleotide comprising a cyclic loop modification bridging a nucleobase and a phosphate group, wherein the cyclic loop modification comprises a reporter encoding the identity of the nucleobase, and an arresting construct adjacent to the reporter.

### Claim 27 (depends on 26)

The cyclic loop nucleotide of claim 26, wherein the arresting construct is adjacent to the reporter.

### Claim 28 (depends on 26)

The cyclic loop nucleotide of claim 26, wherein the arresting construct comprises a linear, branched, cyclic, or dendritic structure.

### Claim 29 (depends on 26)

The cyclic loop nucleotide of claim 26, wherein the cyclic loop nucleotide has one of the following structures:
wherein:
X is —O—, —CH2—, —NSO2—, —NH—,
X′ is —S—, ═N—SO2—; ═NH—CO—, or
Base is the nucleobase;
L1 and L2 are each a linking group;
RP is the reporter encoding the nucleobase;
and ARC is the arresting construct.

### Claim 30 (depends on 29)

The cyclic loop nucleotide of claim 29, wherein the ARC is covalently attached to the cyclic loop via a covalent coupling selected from amine-NHS ester, amine-imidoester, amine-pentofluorophenyl ester, amine-hydroxymethyl phosphine, carboxyl-carbodiimide, thiol-maleimide, thiol-haloacetyl, thiol-pyridyl disulfide, thiol-thiosulfonate, thiol-vinyl sulfone, aldehyde-hydrazide, aldehyde-alkoxyamine, hydroxy-isocyanate, azide-alkyne, azide-phosphine, transcyclooctene-tetrazine, norbornene-tetrazine, azide-cyclooctyne, and azide-norbornene.

### Claim 31 (depends on 26)

A kit for performing a method for determining a sequence of a target polynucleotide in a nanopore-based sequencing system, the kit comprising one or more cyclic loop nucleotides according to claim 26.
